Fairvalue-Calculator Fairvalue-Calculator
EN DE

Generic Sweden AB (GENI) Fair Value & Analysis

Technology · SE · Market cap 479M SEK

GS Generic Sweden AB GENI · ST
Pricekr 37.85
Fair Valuekr 46.59
Upside+23.1%
Quality95/100
Evidence: High Range kr 35.38 – kr 58.71

Fair value as of: Jun 24, 2026

From 24 valuation models · updated 5 days ago

Share price −4.7% over the past month.

Price vs Fair Value (12 months)

kr 54.36 kr 32.01 Fair Value kr 46.59 Jun 2025 Jun 2026

12‑month range kr 32.01 – kr 54.36 · fair‑value band kr 35.38 – kr 58.71 · the kr 37.85 price screens below the kr 46.59 fair value. As of Jun 24, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Generic Sweden AB (GENI) currently trades at kr 37.85, while our model-based Fair Value estimate is kr 46.59 — implying the stock looks roughly 23.1% undervalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, Generic Sweden AB generated revenue of 189M SEK at a net margin of 16.4%. Revenue grew 9.7% year over year. It earns a return on equity of 45.3%. The balance sheet holds a net cash position of 58.2M SEK. Fundamentals as of Jun 24, 2026

Key figures & financial health

Revenue (TTM) 189M SEK
Revenue growth (YoY) +9.7%
Net margin 16.4%
Return on equity 45.3%
Free cash flow 39.0M SEK FY2025
P/E ratio 15.5
More key figures
Operating margin 19.8%
EPS (TTM) kr 2.52
Dividend yield 4.5%
EPS growth (YoY) +0.5%
Net cash 58.2M SEK FY2025

Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.

About the company

Generic Sweden AB, a technology company, provides messaging services for all applications. It also offers digital communication services through a communication platform as a service (CPaaS) model. Generic Sweden AB was incorporated in 1993 and is headquartered in Stockholm, Sweden.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Generic Sweden AB reported revenue of kr 184M in FY2025 versus kr 114M in FY2021, a compound +12.6%/yr. Reported net income was kr 31.0M in FY2025, compounding +14.4%/yr from FY2021.

Revenue +12.6%/yr
FY21 kr 114M
FY22 kr 128M
FY23 kr 143M
FY24 kr 176M
FY25 kr 184M
Net income +14.4%/yr
FY21 kr 18.1M
FY22 kr 20.4M
FY23 kr 23.3M
FY24 kr 27.3M
FY25 kr 31.0M

Open the full interactive analysis →

Similar stocks

6 more Software - Application stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).

Stock Price Fair Value vs Fair Value
SAP SE SAPP34 R$949.05 R$674.65 -29%
Salesforce, Inc CRM $153.42 $182.10 +19%
Uber Technologies, Inc UBER $68.61 $88.21 +29%
Shopify Inc SHOP $109.54 $30.42 -72%
ServiceNow, Inc NOW $127.65 $35.40 -72%
Cadence Design Systems, Inc CDNS $389.04 $80.41 -79%

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Generic Sweden AB (GENI) undervalued?
As of Jun 24, 2026, our model estimates a fair value of kr 46.59 versus a price of kr 37.85 — about +23% (undervalued). Model-based estimate, not financial advice.
What is the fair value of GENI?
Our 21-model fair value for Generic Sweden AB is kr 46.59 (as of Jun 24, 2026), built from audited fundamentals. The current price is kr 37.85.
What is the quality score of GENI?
Generic Sweden AB has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of Generic Sweden AB (GENI)?
Generic Sweden AB reported trailing-twelve-month revenue of about 189M SEK (latest available figure, as of Jun 24, 2026).
What is the net profit margin of GENI?
The net profit margin of Generic Sweden AB is about 16.4%, meaning it keeps roughly 16.4% of revenue as net income. Based on the latest reported figures.
Does Generic Sweden AB pay a dividend?
Generic Sweden AB currently shows a dividend yield of about 4.49% relative to its recent price (as of Jun 24, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.